| Stop & Shop Pharmacy # 782 | |
| 1282 Springfield St, Feeding Hills, Massachusetts 01030 | |
| (413) 789-2226 |
| Name | Stop & Shop Pharmacy # 782 |
|---|---|
| Organization Name | Stop And Shop Supermarket Co Llc. |
| Location | 1282 Springfield St, Feeding Hills, Massachusetts 01030 |
| Type | Community/Retail Pharmacy |
| Phone | (413) 789-2226 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Women who experience pelvic girdle syndrome during pregnancy and undergo cesarean section are still at an increased risk for PGS 6 months after childbirth, research shows.
HemaCare Corporation announced today that the Company generated 2011 third quarter revenue of $4.0 million from continuing operations and net income of $512,000 or $0.05/share, including net income from discontinued operations of $1,090,000.
Flexion Therapeutics, Inc. announced today that new data from a Phase 2b dose-ranging trial of the company's lead compound, FX006, in osteoarthritis has been accepted for an oral presentation at the 2013 Annual Scientific Meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals.
Evidence of grid cell activity has been seen in healthy volunteers asked to imagine moving through an environment in new UCL research funded by the Medical Research Council and Wellcome Trust.
› Verified 9 days ago
| NPI Number | 1679177349 |
| Type | Community/Retail Pharmacy |
| Address | 1282 Springfield St, Feeding Hills, MA 01030 |
| Phone Number | 413-789-2226 |
News Archive
Women who experience pelvic girdle syndrome during pregnancy and undergo cesarean section are still at an increased risk for PGS 6 months after childbirth, research shows.
HemaCare Corporation announced today that the Company generated 2011 third quarter revenue of $4.0 million from continuing operations and net income of $512,000 or $0.05/share, including net income from discontinued operations of $1,090,000.
Flexion Therapeutics, Inc. announced today that new data from a Phase 2b dose-ranging trial of the company's lead compound, FX006, in osteoarthritis has been accepted for an oral presentation at the 2013 Annual Scientific Meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals.
Evidence of grid cell activity has been seen in healthy volunteers asked to imagine moving through an environment in new UCL research funded by the Medical Research Council and Wellcome Trust.
› Verified 9 days ago
| NPI Number | 1780618652 |
| Organization Name | STOP AND SHOP SUPERMARKET CO LLC |
| Doing Business As | STOP AND SHOP PHARMACY 782 |
| Type | Pharmacy |
| Address | 1282 Springfield St, Feeding Hills, MA 01030 |
| Phone Number | 413-789-2226 |
News Archive
Women who experience pelvic girdle syndrome during pregnancy and undergo cesarean section are still at an increased risk for PGS 6 months after childbirth, research shows.
HemaCare Corporation announced today that the Company generated 2011 third quarter revenue of $4.0 million from continuing operations and net income of $512,000 or $0.05/share, including net income from discontinued operations of $1,090,000.
Flexion Therapeutics, Inc. announced today that new data from a Phase 2b dose-ranging trial of the company's lead compound, FX006, in osteoarthritis has been accepted for an oral presentation at the 2013 Annual Scientific Meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals.
Evidence of grid cell activity has been seen in healthy volunteers asked to imagine moving through an environment in new UCL research funded by the Medical Research Council and Wellcome Trust.
› Verified 9 days ago
News Archive
Women who experience pelvic girdle syndrome during pregnancy and undergo cesarean section are still at an increased risk for PGS 6 months after childbirth, research shows.
HemaCare Corporation announced today that the Company generated 2011 third quarter revenue of $4.0 million from continuing operations and net income of $512,000 or $0.05/share, including net income from discontinued operations of $1,090,000.
Flexion Therapeutics, Inc. announced today that new data from a Phase 2b dose-ranging trial of the company's lead compound, FX006, in osteoarthritis has been accepted for an oral presentation at the 2013 Annual Scientific Meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals.
Evidence of grid cell activity has been seen in healthy volunteers asked to imagine moving through an environment in new UCL research funded by the Medical Research Council and Wellcome Trust.
› Verified 9 days ago
Stop & Shop Pharmacy # 782 Type: Community/Retail Pharmacy Location: 1282 Springfield St, Feeding Hills, Massachusetts 01030 Phone: (413) 789-2226 |